Cargando…

From Cancer Epidemiology to Policy and Practice: the Role of a Comprehensive Cancer Center

PURPOSE OF REVIEW: Cancer incidence and mortality are decreasing, but inequities in outcomes persist. This paper describes the San Francisco Cancer Initiative (SF CAN) as a model for the systematic application of epidemiological evidence to reduce the cancer burden and associated inequities. RECENT...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiatt, Robert A., Sibley, Amanda, Venkatesh, Brinda, Cheng, Joyce, Dixit, Niharika, Fox, Rena, Ling, Pamela, Nguyen, Tung, Oh, Debora, Palmer, Nynikka R., Pasick, Rena J., Potter, Michael B., Somsouk, Ma, Vargas, Roberto Ariel, Vijayaraghavan, Maya, Ashworth, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935108/
https://www.ncbi.nlm.nih.gov/pubmed/35342686
http://dx.doi.org/10.1007/s40471-021-00280-7
Descripción
Sumario:PURPOSE OF REVIEW: Cancer incidence and mortality are decreasing, but inequities in outcomes persist. This paper describes the San Francisco Cancer Initiative (SF CAN) as a model for the systematic application of epidemiological evidence to reduce the cancer burden and associated inequities. RECENT FINDINGS: SF CAN is a multi-institutional implementation of existing evidence on the prevention and early detection of five common cancers (i.e., breast, prostate, colorectal, liver, and lung/tobacco-related cancers) accounting for 50% of cancer deaths in San Francisco. Five Task Forces follow individual logic models designating inputs, outputs, and outcomes. We describe the progress made and the challenges faced by each Task Force after 5 years of activity. SUMMARY: SF CAN is a model for how the nation’s Comprehensive Cancer Centers are ideally positioned to leverage cancer epidemiology for evidence-based initiatives that, along with genuine community engagement and multiple stakeholders, can reduce the population burden of cancer.